Search

Home > New FDA Approvals > 113 – Tasigna approved for children with CML; FDA approves ranibizumab injection) 0.3 mg Prefilled Syringe; FDA Clearance for HandX; ExSpiron for Pediatric Patients
Podcast: New FDA Approvals
Episode:

113 – Tasigna approved for children with CML; FDA approves ranibizumab injection) 0.3 mg Prefilled Syringe; FDA Clearance for HandX; ExSpiron for Pediatric Patients
Category: Science & Medicine
Duration: 00:09:17
Publish Date: 2018-03-23 07:00:00
Description:

March 23, 2018 

Please subscribe, rate and review if you like this podcast. Thank you! The podcast website is http://newfdaapprovals.com

1:23 Novartis drug Tasigna® approved by FDA to treat children with chronic myeloid leukemia https://www.prnewswire.com/news-releases/novartis-drug-tasigna-approved-by-fda-to-treat-children-with-rare-form-of-leukemia-300618326.html

3:02 FDA Approves Genentech’s Lucentis (ranibizumab injection) 0.3 mg Prefilled Syringe for Diabetic Macular Edema and Diabetic Retinopathy | Business Wire https://www.businesswire.com/news/home/20180321005688/en/FDA-Approves-Genentech%E2%80%99s-Lucentis-ranibizumab-injection-0.3

5:11 FDA Clearance for HandX, the First in a Line of Smart Digital Handtop Solutions https://www.prnewswire.com/news-releases/human-xtensions-receives-fda-clearance-for-its-handx-the-first-in-a-line-of-smart-digital-handtop-solutions-677636573.html

6:26 FDA clearance for use of the ExSpiron™ 1Xi Minute Ventilation Monitor in Pediatric Patients https://www.prnewswire.com/news-releases/respiratory-motion-inc-is-excited-to-announce-fda-clearance-for-use-of-the-exspiron-1xi-minute-ventilation-monitor-in-pediatric-patients-300617953.html

The next 6-week course will begin on Monday April 9th, 2018. Registration for the course will begin on Monday April 2nd, at noon EDT and will close on Saturday April 7th at noon EDT. Log on to learn.6weekcourse.com to register. Music credit: freemusicarchive.org/music/MindsEye/Yellow_Taxi/
Total Play: 0